- Overview
- Bayer Group
- Stock
- Bonds
- Reports
- Annual Stockholders’ Meeting 2015
- Events
- News
- Investor News
- Ad-hoc Publications
- Press
- Archive
- Overview
- Investor News 2014
- Investor News 2013
- Investor News 2012
- Investor News 2011
- Investor News 2010
- Investor News 2009
- Investor News 2008
- Investor News 2007
- Investor News 2006
- Investor News 2005
- Investor News 2004
- Investor News 2003
- Investor News 2002
- Investor News 2001
- Investor News 2000
- Ad-hoc 2014
- Ad-hoc 2013
- Ad-hoc 2012
- Ad-hoc 2011
- Ad-hoc 2010
- Ad-hoc 2009
- Ad-hoc 2008
- Ad-hoc 2007
- Ad-hoc 2006
- Ad-hoc 2005
- Ad-hoc 2004
- Ad-hoc 2003
- Ad-hoc 2002
- Ad-hoc 2001
- Ad-hoc 2000
- Ad-hoc 1999
- Ad-hoc 1998
- Handouts
- Downloads
Ad-hoc Publications
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
2014
| September 18, 2014 | Strategic corporate decision: Bayer plans to focus entirely on Life Science businesses | Download ( PDF, 29 KB )collect |
| September 18, 2014 | Strategic corporate decision: Bayer Board of Management plans to focus entirely on Life Science businesses | Download ( PDF, 27 KB )collect |
2013
No Ad-hoc Messages were issued in year 2013.
2012
No Ad-hoc Messages were issued in year 2012.
2011
| September 29, 2011 | Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint | Download ( PDF, 87 KB )collect |
| September 6, 2011 | Bayer AG: FDA has published documents for discussion at the Advisory Committee on the new drug application for Rivaroxaban | Download ( PDF, 124 KB )collect |
2010
| October 31, 2010 | Bayer AG: Phase III ROCKET AF Study of Rivaroxaban meets its primary efficacy endpoint with Comparable Safety vs. Warfarin | Download ( PDF, 41 KB )collect |
| August 4, 2010 | Bayer AG: Rivaroxaban Meets Primary Endpoint in Long-Term Phase III EINSTEIN-DVT Study | Download ( PDF, 37 KB )collect |
2009
| September 15, 2009 | Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010 | Download ( PDF, 35 KB )collect |
2008
| March 3, 2008 | Bayer AG: Court Decides against the Company’s Yasmin® Patent | Download ( PDF, 36 KB )collect |
2007
| April 26, 2007 | Bayer exceeds consensus estimates for Q1 2007 | Download ( PDF, 63 KB )collect |
Previous ad-hoc publications can be found in the Archive.
